John William Tanner - 26 Jan 2024 Form 4 Insider Report for CervoMed Inc. (CRVO)

Reporting relationship: Chief Financial Officer
Issuer ticker: CRVO
Reported as of: 26 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Jan 2024, 18:46:09 UTC
Prior SEC filing: 22 Nov 2023
Source filing: View source filing
Reporting owner signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person

Key filing fact

John William Tanner filed Form 4 for CervoMed Inc. (CRVO) on 26 Jan 2024.

Key facts

This page summarizes John William Tanner's Form 4 filing for CervoMed Inc. (CRVO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Jan 2024, 18:46.

Change

Previous filing in this sequence was filed on 22 Nov 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +16,000
Change %
Price: $0.000000
Shares after: 16,000
Date: 26 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,000
Exercise price: $9.05
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024.